Catalysts for $IGC
651 tracked
Feb 21, 2025
approval
BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE (BUPRENORPHINE HYDROCHLORIDE) — FDA approval
IGC Pharma, Inc.
→
Feb 21, 2025
approval
BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE (BUPRENORPHINE HYDROCHLORIDE) — FDA approval
IGC Pharma, Inc.
→
Feb 11, 2025
approval
HYDROCODONE BITARTRATE AND ACETAMINOPHEN (ACETAMINOPHEN) — FDA approval
IGC Pharma, Inc.
→
Nov 20, 2024
recall
Trinity Gold Nutrition recall (Cls II)
IGC Pharma, Inc.
→
Nov 20, 2024
approval
HYDROCODONE BITARTRATE AND ACETAMINOPHEN (ACETAMINOPHEN) — FDA approval
IGC Pharma, Inc.
→
Nov 20, 2024
approval
OXYCODONE AND ACETAMINOPHEN (ACETAMINOPHEN) — FDA approval
IGC Pharma, Inc.
→
Oct 31, 2024
approval
HYDROCODONE BITARTRATE AND ACETAMINOPHEN (ACETAMINOPHEN) — FDA approval
acetaminophen ER
→
Oct 31, 2024
approval
OXYCODONE AND ACETAMINOPHEN (ACETAMINOPHEN) — FDA approval
IGC Pharma, Inc.
→
Oct 31, 2024
approval
HYDROCODONE BITARTRATE AND ACETAMINOPHEN (ACETAMINOPHEN) — FDA approval
IGC Pharma, Inc.
→
Oct 31, 2024
approval
HYDROCODONE BITARTRATE AND ACETAMINOPHEN (ACETAMINOPHEN) — FDA approval
IGC Pharma, Inc.
→
Oct 31, 2024
approval
HYDROCODONE BITARTRATE AND ACETAMINOPHEN (ACETAMINOPHEN) — FDA approval
IGC Pharma, Inc.
→
Oct 31, 2024
approval
HYDROCODONE BITARTRATE AND ACETAMINOPHEN (ACETAMINOPHEN) — FDA approval
IGC Pharma, Inc.
→
Oct 31, 2024
approval
HYDROCODONE BITARTRATE AND ACETAMINOPHEN (ACETAMINOPHEN) — FDA approval
IGC Pharma, Inc.
→
Oct 31, 2024
approval
HYDROCODONE BITARTRATE AND ACETAMINOPHEN (ACETAMINOPHEN) — FDA approval
IGC Pharma, Inc.
→
Oct 31, 2024
approval
HYDROCODONE BITARTRATE AND ACETAMINOPHEN (ACETAMINOPHEN) — FDA approval
IGC Pharma, Inc.
→
Oct 31, 2024
approval
HYDROCODONE BITARTRATE AND ACETAMINOPHEN (ACETAMINOPHEN) — FDA approval
IGC Pharma, Inc.
→
Oct 31, 2024
approval
FIORICET W/ CODEINE (ACETAMINOPHEN) — FDA approval
IGC Pharma, Inc.
→
Oct 31, 2024
approval
BELBUCA (BUPRENORPHINE HYDROCHLORIDE) — FDA approval
IGC Pharma, Inc.
→
Oct 31, 2024
approval
HYDROCODONE BITARTRATE AND ACETAMINOPHEN (ACETAMINOPHEN) — FDA approval
IGC Pharma, Inc.
→
Oct 31, 2024
approval
HYDROCODONE BITARTRATE AND ACETAMINOPHEN (ACETAMINOPHEN) — FDA approval
IGC Pharma, Inc.
→
Oct 31, 2024
approval
HYDROCODONE BITARTRATE AND ACETAMINOPHEN (ACETAMINOPHEN) — FDA approval
IGC Pharma, Inc.
→
Oct 31, 2024
approval
HYDROCODONE BITARTRATE AND ACETAMINOPHEN (ACETAMINOPHEN) — FDA approval
acetaminophen ER
→
Oct 31, 2024
approval
PERCOCET (ACETAMINOPHEN) — FDA approval
IGC Pharma, Inc.
→
Oct 31, 2024
approval
OXYCODONE AND ACETAMINOPHEN (ACETAMINOPHEN) — FDA approval
IGC Pharma, Inc.
→
Oct 31, 2024
approval
OXYCODONE AND ACETAMINOPHEN (ACETAMINOPHEN) — FDA approval
IGC Pharma, Inc.
→
Oct 31, 2024
approval
OXYCODONE AND ACETAMINOPHEN (ACETAMINOPHEN) — FDA approval
IGC Pharma, Inc.
→
Oct 31, 2024
approval
HYDROCODONE BITARTRATE AND ACETAMINOPHEN (ACETAMINOPHEN) — FDA approval
IGC Pharma, Inc.
→
Oct 31, 2024
approval
OXYCODONE AND ACETAMINOPHEN (ACETAMINOPHEN) — FDA approval
IGC Pharma, Inc.
→
Oct 31, 2024
approval
OXYCODONE AND ACETAMINOPHEN (ACETAMINOPHEN) — FDA approval
IGC Pharma, Inc.
→
Oct 31, 2024
approval
PERCOCET (ACETAMINOPHEN) — FDA approval
IGC Pharma, Inc.
→